REG - Surgical Innovations - Notice of Interim Results

Surgical InnovationsAnnouncement

27/08/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210827:nRSa9299Ja&default-theme=true

RNS Number : 9299J  Surgical Innovations Group PLC  27 August 2021

Surgical Innovations Group plc

(the "Company", "SI" or the "Group")

 

Notice of Interim Results

Investor presentation

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and
distributor of innovative technology for minimally invasive surgery, announces
that it will release its interim results for the six months ended 30 June
2021, on Wednesday 15 September 2021.

 

Analyst Briefing

A briefing open to analysts will take place remotely via video conference call
on Wednesday 15 September at 09.30 (BST). If you would like the details of
this call please contact Walbrook PR on si@walbrookpr.com
(mailto:si@walbrookpr.com) .

 

Investor Presentation

David Marsh, Chief Executive Officer, and Charmaine Day, Company Secretary and
Group Financial Controller will provide a live presentation relating
to Half-year Results via the Investor Meet Company platform on Thursday 16
September 2021 at 4:30pm BST.

 

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet
Surgical Innovations Group plc via:

 

https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor
(https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor)

 

Investors who already follow Surgical Innovations Group plc on the Investor
Meet Company platform will automatically be invited.

 

 

For further information please contact:

 

 Surgical Innovations Group plc           www sigroupplc com
 David Marsh, CEO                         Tel: 0113 230 7597
 Charmaine Day, Co Sec & GFC

 Singer Capital Markets (Nominated Adviser & Broker)                                        Tel: 020 7496 3000
 Aubrey Powell / Rachel Hayes/ Iqra Amin

 Walbrook PR (Financial PR & Investor Relations)                      Tel: 020 7933 8780 or si@walbrookpr.com
 Paul McManus / Lianne Cawthorne          Mob: 07980 541 893 / 07584 391 303

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of
innovative, high quality medical products, primarily for use in minimally
invasive surgery. Our product and business development is guided and supported
by a key group of nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical
instruments and retraction devices which are sold directly in the UK home
market through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of our
products in this field are based on a "resposable" concept, in which the
products are part re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive against
fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist
products employed in laparoscopy, bariatric and metabolic surgery, hernia
repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM
partners and have also collaborated with a major UK industrial partner to
provide precision engineering solutions to complex problems outside the
medical arena.

 

We aim for our brands to be recognised and respected by healthcare
professionals in all major geographical markets in which we operate and
provide by development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable devices
that offer reliable solutions to genuine clinical needs in the operating
theatre environment.

 

The Group currently employs approximately 100 people across two sites in the
UK. Product design, engineering and manufacturing are carried out at the SI
site in Yorkshire. Commercial activities including marketing, UK distribution
and international sales and marketing are based at Elemental Healthcare in
Berkshire. internationally the Group sells into 47 countries with strong
markets In the North American and APAC regions

 

Further information

 

Further details of the Group's businesses and products are available on the
following websites:

 

www sigroupplc com

www surginno com

www elementalhealthcare co.uk

 

To receive regular updates by email, please contact si@walbrookpr.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORXQLFLFVLEBBK